SEC 13F Intelligence

Managers / Q1 2022 · view latest →

SECTORAL ASSET MANAGEMENT INC

CIK 0001274413 · 1010 SHERBROOKE ST., WEST, SUITE 1610, MONTREAL, A8, H3A 2R7 · 514 849 8777

Reported Value
$563M
Q1 2022
Positions
106
Filings on Record
30
2019–present window
Filed
May 10, 2022
original filing

Summary

Sectoral Asset Management Inc reported $563M in U.S.-listed holdings across 106 positions for Q1 2022.

Its largest position, UNH, represents 3.0% of the portfolio.

Compared with Q4 2021, the fund opened 15 new positions and exited 17.

Portfolio Metrics

Turnover
+17.0%
vs prior filed quarter
Top-10 Concentration
+25.1%
share of reported value
Largest Position
+3.0%
Unitedhealth
New / Exited
15 / 17
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $736MQ4 ’18Q1 ’19: $831MQ2 ’19: $836MQ3 ’19: $580MQ4 ’19: $670MQ4 ’19Q1 ’20: $521MQ2 ’20: $1.1BQ3 ’20: $1.2BQ4 ’20: $1.4BQ4 ’20Q1 ’21: $1.3BQ2 ’21: $1.2BQ3 ’21: $1.2BQ4 ’21: $664MQ4 ’21Q1 ’22: $563MQ2 ’22: $496MQ3 ’22: $508MQ4 ’22: $517MQ4 ’22Q1 ’23: $520MQ2 ’23: $600MQ3 ’23: $514MQ4 ’23: $232MQ4 ’23Q1 ’24: $254MQ2 ’24: $246MQ3 ’24: $169MQ4 ’24: $150MQ4 ’24Q1 ’25: $128MQ2 ’25: $151MQ3 ’25: $162MQ4 ’25: $125MQ4 ’25Q1 ’26: $121Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 84.8%Other: 14.2%ADR: 1.1%
  • Common Stock · 84.8% · $478M
  • Other · 14.2% · $80M
  • ADR · 1.1% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HQYHEALTHEQUITY INCNEW+240.0K240.0K+$16M$16M
BIOHAVEN PHARMACEUTICAL HOLDING CONEW+105.8K105.8K+$13M$13M
OMGBPOUTSET MED INCNEW+111.3K111.3K+$5M$5M
HALOHALOZYME THERAPEUTICS INCNEW+126.0K126.0K+$5M$5M
IRTCIRHYTHM TECHNOLOGIES INCNEW+28.8K28.8K+$5M$5M
IMGNEURIMMUNOGEN INCNEW+878.8K878.8K+$4M$4M
IOVAIOVANCE BIOTHERAPEUTICS INCNEW+222.0K222.0K+$4M$4M
APLSUSDAPELLIS PHARMACEUTICALS, INCNEW+69.5K69.5K+$4M$4M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2022

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1UNHUNITEDHEALTH GROUP INChistory →COM2.96%$17M32.7K
2HQYHEALTHEQUITY INChistory →COM2.87%$16M240.0K
3INARI MED INCCOM2.59%$15M161.1K
4ATRCATRICURE INChistory →COM2.54%$14M218.2K
58INSYNEOS HEALTH INChistory →CL A2.53%$14M176.3K
6RCMEURR1 RCM INChistory →COM2.51%$14M528.5K
7INSPINSPIRE MED SYS INChistory →COM2.35%$13M51.6K
8JNJJOHNSON & JOHNSONhistory →COM2.29%$13M72.8K
9EVHEVOLENT HEALTH INChistory →CL A2.25%$13M392.1K
10BIOHAVEN PHARMACEUTICAL HOLDING COCOM2.23%$13M105.8K
11IM8NINSMED INChistory →COM2.20%$12M528.3K
12ORTHO CLINICAL DIAGNOSTICS HORD SHS2.20%$12M665.3K
13THCTENET HEALTHCARE CORPhistory →COM2.18%$12M143.0K
14ARVNARVINAS INChistory →COM1.98%$11M166.1K
15RCUSARCUS BIOSCIENCES INChistory →COM1.90%$11M338.5K
16AGILITI INCCOM1.80%$10M479.6K
17TMOTHERMO FISHER SCIENTIFIC INChistory →COM1.75%$10M16.7K
18PTCTPTC THERAPEUTICS INChistory →COM1.75%$10M264.4K
19ABBVABBVIE INChistory →COM1.74%$10M60.3K
20PRVAPRIVIA HEALTH GROUP INChistory →COM1.72%$10M361.6K
21PFEPFIZER INChistory →COM1.70%$10M184.9K
22EFFECTOR THERAPEUTCS INCCOM1.70%$10M2.38M
23TNDMTANDEM DIABETES CARE INChistory →COM1.64%$9M79.6K
24SILKUSDSILK ROAD MEDICAL INChistory →COM1.53%$9M209.0K
25EX9EXELIXIS INChistory →COM1.46%$8M363.8K
26LLYLILLY ELI & COhistory →COM1.45%$8M28.5K
27BMRNBIOMARIN PHARMACEUTICAL INChistory →COM1.44%$8M105.1K
28TURNING POINT THERAPEUTICS INCCOM1.34%$8M280.9K
292662247DITEOS THERAPEUTICS INChistory →COM1.34%$8M234.2K
30FATEFATE THERAPEUTICS INChistory →COM1.33%$7M193.2K
31SWAVUSDSHOCKWAVE MEDICAL INChistory →COM1.29%$7M35.0K
32ABTABBOTT LABShistory →COM1.25%$7M59.5K
33DNLIDENALI THERAPEUTICS INChistory →COM1.18%$7M207.1K
34HCATHEALTH CATALYST INChistory →COM1.17%$7M251.7K
35SGENUSDSEAGEN INChistory →COM1.05%$6M41.1K
36AM6AMICUS THERAPEUTICS INChistory →COM1.05%$6M623.8K
37ARWRARROWHEAD PHARMACEUTICALS INCCOM0.98%$6M119.7K
38CERTCERTARA INCCOM0.97%$5M255.6K
39BLUBELLUS HEALTH INC NEWCOM NEW0.97%$5M790.6K
40NTLAINTELLIA THERAPEUTICS INCCOM0.93%$5M72.2K
412655787DBLUEPRINT MEDICINES CORPCOM0.93%$5M81.9K
42HORIZON THERAPEUTICS PUB LSHS0.92%$5M49.5K
43OMGBPOUTSET MED INCCOM0.90%$5M111.3K
44HALOHALOZYME THERAPEUTICS INCCOM0.89%$5M126.0K
45HUMHUMANA INCCOM0.89%$5M11.5K
46STAASTAAR SURGICAL COCOM0.89%$5M62.5K
47MRTXEURMIRATI THERAPEUTICS INCCOM0.87%$5M59.8K
48RCKTROCKET PHARMACEUTICALSCOM0.86%$5M304.0K
49MRKMERCK & CO INCCOM0.84%$5M57.8K
50BSXBOSTON SCIENTIFIC CORPCOM0.81%$5M102.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$121M77May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$125M74Feb 9, 202613F-HRchanges · EDGAR ↗
Q3 2025$162M82Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$151M94Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$128M84May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$150M86Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$169M90Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$246M97Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$254M92May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$232M104Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$514M123Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$600M121Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$520M118May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$517M120Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$508M109Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$496M112Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$563M106May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$664M108Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.2B127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.2B127Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.3B113May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.4B97Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.2B88Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B191Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$521M65May 13, 202013F-HRchanges · EDGAR ↗
Q4 2019$670M65Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$580M63Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$836M92Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$831M106May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$736M104Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.